Singapore’s pharmaceutical market is expected to increase from $903m in 2016 to $1.15bn in 2021 in value, representing a compound annual growth rate of approximately 5%, according to a report by GlobalData.

Titled ‘CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Singapore’, the report states universal access to health insurance schemes and world-class biomedical sciences research facilities to be the main factors driving Singapore’s healthcare market.

Despite a smaller population compared to other developed countries, Singapore ranked fourth globally in 2010 for its healthcare infrastructure.

It has also emerged as a regional hub for manufacturing and R&D activities for several multi-national pharmaceutical companies, states Sama Khan, Healthcare Analyst at GlobalData. The country boasts of several medical technology hubs, including MedTech, Biopolis and Tuas Biomedical Park, where pharmaceuticals and medical devices are developed.

“Despite a smaller population compared to other developed countries, Singapore ranked fourth globally in 2010 for its healthcare infrastructure.”

Furthermore, Singapore ranked first in the 2016 Business Environment Risk Intelligence (BERI) among 50 countries. A pro-business corruption-free environment with strong government support, low labour costs and low corporate tax has created a favourable environment for pharmaceutical companies.

The Singapore Government also provides universal healthcare coverage. The per-capita expenditure on health increased from $1,656 in 2009 to $2,752 in 2014 and is expected to increase further due to a growing elderly population.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

A favourable economic environment, efficient healthcare infrastructure and increasing public healthcare expenditure will drive the market growth in the future, Khan adds.